Sublingual versus vaginal misoprostol (400 μg) for cervical priming in first-trimester abortion: a randomized trial

Contraception

Volumn 74, Issue 4, 2006, Pages 328-333

  Carbonell Esteve, Josep Lluis ^a   Marí, Jose Maria ^a   Valero, Francisco ^b   Llorente, Margardel ^a   Salvador, Immaculada ^a   Varela, Lidia ^a   Leal, Pedro ^a   Candel, Ana ^a   Tudela, Ana ^a   Serrano, Maria ^a   Muñoz, Eva ^a  

^a Mediterranea Medica Clinic   (Spain)

^b Clínica Ginemur   (Spain)

Author keywords

Cervical priming; Early abortion; Misoprostol

Indexed keywords

MISOPROSTOL;

ADULT; ARTICLE; CHILL; DIARRHEA; DRUG EFFICACY; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; OUTCOMES RESEARCH; PARESTHESIA; PREGNANCY; PREGNANCY TERMINATION; UTERINE CERVIX DILATATION; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, SUBLINGUAL; ADULT; CERVICAL RIPENING; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TREATMENT OUTCOME;

EID: 33748699658     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.03.031     Document Type: Article

References (18)

1. Grimes D.A., Schulz K.F., and Cates Jr. W.J. Prevention of uterine perforation during curettage abortion. JAMA 251 (1984) 2108-2111
2. Schulz K.F., Grimes D.A., and Cates Jr. W.J. Measures to prevent cervical injuries during suction curettage abortion. Lancet 1 (1983) 1182-1185
3. Royal College of Obstetricians and Gynaecologists. Clinical effectiveness support unit: the care of women requesting induced abortion: national evidence bases clinical guidelines (2000), RCOG Press, London
4. Carbonell J.L.L., Varela L., Velazco A., Tanda R., and Sanchez C. Early abortion with 800 μg of misoprostol by the vaginal route. Contraception 59 (1999) 219-225
5. Carbonell J.L.L., Varela L., Velazco A., Tanda R., Cabezas E., and Sanchez C. Vaginal misoprostol for early second trimester abortion. Eur J Contracpt Reprod Health Care 3 (1998) 93-98
6. Carbonell J.LL., Velazco A., Rodriguez Y., et al. Oral versus vaginal misoprostol for cervical priming in first trimester abortion. A randomized trial. Eur J Contracpt Reprod Health Care 6 (2001) 134-140
7. Oppergaard K., Abdelnoor M., Nesheim B.I., Jerve F., and Eskild A. The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 μg in first trimester pregnancies. BJOG 111 (2004) 154-159
8. Hamoda H., Ashok P., Flett G.M.M., and Templeton A. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion. Am J Obstet Gynecol 190 (2004) 55-59
9. MacIssac L., Grossman D., Balisteri E., and Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol 93 (1999) 766-770
10. Tang O.S., Schweer H., Seyberth H.W., Lee W.H., and Ho P.C. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 64 (2002) 332-336
11. Tang O.S., and Ho P.C. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 64 (2001) 315-317
12. Tang O.S., Miao B.Y., Lee S.W., and Ho P.C. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability. Hum Reprod 17 (2002) 654-658
13. Hadlock F.P., Shah Y.P., Kanon D.J., Math B., and Lindsey J.V. Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high resolution real-time US. Radiology 182 (1992) 501-505
14. Machin D., and Campbell M.J. Statistical tables for the design clinical trials (1987), Blackwell Scientific Publications, Oxford
15. Aronsson A., Helström L., and Gemzell-Danielsson K. Sublingual compared with oral misoprostol for cervical dilation prior to uterine aspiration: a randomized comparison. Contraception 69 (2004) 165-169
16. Vimala N., Mittal S., Kumar S., et al. A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of first-trimester pregnancy. Contraception 70 (2004) 117-120
17. Saxena P., Salhan S., and Sarda N. Role of sublingual misoprostol for cervical ripening prior to vacuum aspiration in first trimester interruption of pregnancy. Contraception 67 (2003) 213-217
18. Tang O.S., Mok K.H., and Ho P.C. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester. Hum Reprod 19 (2004) 1101-1104